Literature DB >> 10382920

Pain and somatosensory dysfunction in acute herpes zoster.

M Haanpää1, P Laippala, T Nurmikko.   

Abstract

OBJECTIVE: To determine the nature of sensory change and its association with pain and allodynia in acute herpes zoster.
DESIGN: Prospective clinical study. PATIENTS: One hundred thirteen immunocompetent patients with acute herpes zoster.
METHODS: Onset, intensity, and quality of pain and severity of rash were recorded. Quantitative somatosensory testing for tactile and thermal thresholds, qualitative pinprick testing, and testing of dynamic and static allodynia were performed within the affected dermatome, its mirror-image dermatome, and in an adjacent dermatome bilaterally.
RESULTS: Acute pain was reported as severe in 50%, moderate in 29%, mild in 12%, and absent in 9% of patients. Preherpetic pain (median = 4 days, range = 1-60 days) was experienced by 71%. Mechanical allodynia, dynamic, static, or both, was found in 37% of patients and was noted to extend one or more dermatomes outside the rash in 12%. In the affected dermatomes, thresholds were elevated for warmth and cold, lowered for heat pain, and unchanged for touch when compared with the contralateral side. Logistic regression analyses showed that compression-evoked allodynia, brush-evoked allodynia, and the history of preherpetic pain were more frequently encountered in patients with severe pain. Sensory threshold changes were not associated with the severity of pain or rash or with the presence of allodynia.
CONCLUSION: Pain, allodynia, and altered sensation are common features of acute herpes zoster. They are likely to result primarily from widespread neural inflammation within the affected afferent system. The sensory changes found in acute herpes zoster are different from those reported in published studies on postherpetic neuralgia and suggest sensitization phenomena and preservation of tactile functions rather than major neural damage. The exact mechanisms for acute herpes zoster pain, however, remain speculative.

Entities:  

Mesh:

Year:  1999        PMID: 10382920     DOI: 10.1097/00002508-199906000-00003

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  11 in total

1.  Chronic Orofacial Pain: Burning Mouth Syndrome and Other Neuropathic Disorders.

Authors:  Raymond C Tait; McKenzie Ferguson; Christopher M Herndon
Journal:  J Pain Manag Med       Date:  2017-01-30

2.  Efficacy of piroxicam patch compared to lidocaine patch for the treatment of postherpetic neuralgia.

Authors:  Jun Young Kim; Hyun Jung Lim; Weon Ju Lee; Seok-Jong Lee; Do Won Kim; Byung Soo Kim
Journal:  Ann Dermatol       Date:  2011-05-27       Impact factor: 1.444

3.  Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia.

Authors:  Jean-Marc G Guedon; Michael B Yee; Mingdi Zhang; Stephen A K Harvey; William F Goins; Paul R Kinchington
Journal:  Virology       Date:  2015-04-11       Impact factor: 3.616

4.  Patient-reported quality of life in patients suffering from acute herpes zoster-a systematic review with meta-analysis.

Authors:  Martin Sollie; Pernille Jepsen; Jens A Sørensen
Journal:  Br J Pain       Date:  2022-02-21

Review 5.  Postherpetic neuralgia: from preclinical models to the clinic.

Authors:  Ada Delaney; Lesley A Colvin; Marie T Fallon; Robert G Dalziel; Rory Mitchell; Susan M Fleetwood-Walker
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

6.  Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin.

Authors:  J-M G Guedon; M Zhang; J C Glorioso; W F Goins; P R Kinchington
Journal:  Gene Ther       Date:  2014-05-15       Impact factor: 5.250

7.  The role of stress in the development of herpes zoster and postherpetic neuralgia.

Authors:  J M Livengood
Journal:  Curr Rev Pain       Date:  2000

8.  Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation.

Authors:  Tao Peng; R Savanh Chanthaphavong; Sijie Sun; James A Trigilio; Khamsone Phasouk; Lei Jin; Erik D Layton; Alvason Z Li; Colin E Correnti; Willem De van der Schueren; Julio Vazquez; Diana R O'Day; Ian A Glass; David M Knipe; Anna Wald; Lawrence Corey; Jia Zhu
Journal:  J Exp Med       Date:  2017-06-29       Impact factor: 14.307

Review 9.  Vaccination against herpes zoster in developed countries: state of the evidence.

Authors:  Mélanie Drolet; Michael N Oxman; Myron J Levin; Kenneth E Schmader; Robert W Johnson; David Patrick; James A Mansi; Marc Brisson
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

10.  Sex differences underlying orofacial varicella zoster associated pain in rats.

Authors:  Crystal Stinson; Mohong Deng; Michael B Yee; Larry L Bellinger; Paul R Kinchington; Phillip R Kramer
Journal:  BMC Neurol       Date:  2017-05-17       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.